News Focus
News Focus
Replies to #48761 on Biotech Values
icon url

poorgradstudent

06/20/07 6:54 PM

#48776 RE: DewDiligence #48761

How is COLY an example of this program-survival bias thingy?

They ran a controlled phase II trial with 110 patients and saw a strong trend. I don't see why it was a stretch to see them advance the program.